Biohaven Ltd.
taldefgrobep
Obesity
Resolved
7days ago
Phase 2 readout Β· Jun 30, 2026
What's at stake
Phase 2 trial results for taldefgrobep in Obesity are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
Β· SEC 8-K
verified 16h ago
βThe study is evaluating the ability of taldefgrobep, administered once-weekly or once-monthly via autoinjector, to achieve high quality weight loss including reducing fat mass and total body weight while also increasing lean muscle mass.β